Moderna is developing an mRNA-based vaccine for norovirus, now in Phase 3 trials, with hopes of approval by 2026 to combat ...
To learn more about the recent bird flu outbreaks, we spoke with Asha Shah, MD, director of infectious diseases and ...
Moderna conducts phase 3 trial for norovirus vaccine as cases rise in the U.S., with results expected in late 2025 or early 2026.
Moderna provided an update on the status of its trial investigating a vaccine candidate for norovirus in a company statement on Monday.
In the winter months, it seems few are safe from some kind of illness — flu, COVID-19, norovirus, colds. But there are things ...
Regarding avian influenza, while there have been outbreaks in poultry farms and flocks, there have been no reported human cases in Ohio. However, the doctor cautioned that people should avoid contact ...
Moderna is testing a norovirus vaccine in a phase three trial. Results could be available as soon as this year.
Illinois had at least 103 outbreaks of the stomach bug norovirus in November and December – a dramatic increase from previous ...
Dr. Ben Weston, chief health policy advisor for Milwaukee County, joins Lake Effect's Joy Powers to talk about how you can ...
Engineering and medical researchers at Penn have developed a groundbreaking framework that can determine the best and most computationally optimized distribution strategy for COVID-19 vaccinations in ...
The misery of the common stomach flu may be coming to an end. Pharmaceutical company Moderna has launched a large-scale Phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback